Skip to main content
Erschienen in: Studies in Comparative International Development 2/2015

01.06.2015

Re-Thinking Pharmaceutical Production in Africa; Insights from the Analysis of the Local Manufacturing Dynamics in Mozambique and Zimbabwe

verfasst von: Giuliano Russo, Geoffrey Banda

Erschienen in: Studies in Comparative International Development | Ausgabe 2/2015

Einloggen

Aktivieren Sie unsere intelligente Suche um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Until recently, consensus existed in certain circles that the African industry was not suitable for cost-effective production of quality, safe drugs. Yet, public and private pharmaceutical enterprises have cropped up on the continent, with some venturing into production of sophisticated and complex drugs, such as antiretrovirals (ARVs). In our study, we analyse and contrast the dynamics of local pharmaceutical manufacturing in Mozambique and Zimbabwe with the objective of understanding why pharmaceutical production in Africa is picking up momentum and the influence of global funding for ARVs in this process. Our analysis identifies two routes of development for local pharmaceutical manufacturing: a favourable economic outlook and support from the international community created the necessary conditions for the development of the nascent pharmaceutical industry in Mozambique, while in Zimbabwe, the presence of an established local industry was instrumental in bringing in favourable, if not always coherent, government regulation. In both countries, the introduction of AIDS treatment created windows of opportunity for local production of pharmaceuticals by increasing public sector demand, providing fresh funds, and providing a justification for government regulation favouring local production. Despite the long-standing and well-known problems that created persistent shortcomings in human resources and in the economic and industrial environments, we conclude that pre-existing developmental roots, international funds and supportive state industrial policies are encouraging more manufacturers to enter the business of local pharmaceutical production in Africa. However, the opportunities brought in by fresh AIDS funds will need to be sensibly managed at both the local and global levels, as the world’s interest on the disease may not last in the long term.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
Such as Saidal in Algeria and Saphad in Tunisia.
 
2
For example, CIPLA and Quality Pharmaceuticals in Uganda.
 
3
General notice 240 of 2002; ‘2. In view of the rapid spread of HIV/AIDS among the population of Zimbabwe, the Minister hereby declares an emergency for a period of 6 months, with effect from the date of promulgation of this notice, for the purpose of enabling the state or a person authorised by the Minister under section 34 of the Act (a) to make or use any patented drug, including any antiretroviral drug, used in the treatment of persons suffering from HIV/AIDS or HIV/AIDS-related conditions and (b) to import any generic drug used in the treatment of persons suffering from HIV/AIDS or HIV/AIDS-related conditions’. Source: http://​www.​wipo.​int/​wipolex/​en/​text.​jsp?​file_​id=​214688 accessed 25 February 2014
 
Literatur
Zurück zum Zitat Banda G. Financing ARV drug manufacture in Zimbabwe: implications for technological capability upgrading and innovation for African local pharmaceutical production. PhD Thesis. UK: The Open University 2012 Banda G. Financing ARV drug manufacture in Zimbabwe: implications for technological capability upgrading and innovation for African local pharmaceutical production. PhD Thesis. UK: The Open University 2012
Zurück zum Zitat Barker C. The Mozambique pharmaceutical policy. Lancet. 1983;2(8353):780–82.CrossRef Barker C. The Mozambique pharmaceutical policy. Lancet. 1983;2(8353):780–82.CrossRef
Zurück zum Zitat Cameron A, Ewen M, Rossdegnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–49. doi:10.1016/S0140-6736(08)61762-6.CrossRef Cameron A, Ewen M, Rossdegnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–49. doi:10.​1016/​S0140-6736(08)61762-6.CrossRef
Zurück zum Zitat Chaudhuri S, Mackintosh M, Mujinja PGM. Indian generics producers, access to essential medicines and local production in Africa: an argument with reference to Tanzania. Eur J Dev Res. 2010;22(4):451–68. doi:10.1057/ejdr.2010.27.CrossRef Chaudhuri S, Mackintosh M, Mujinja PGM. Indian generics producers, access to essential medicines and local production in Africa: an argument with reference to Tanzania. Eur J Dev Res. 2010;22(4):451–68. doi:10.​1057/​ejdr.​2010.​27.CrossRef
Zurück zum Zitat CMAM. “Proposta de Necessidades E Alocação de Recursos Para Medicamentos”. Ministério da Saúde de Moçambique 2011. CMAM. “Proposta de Necessidades E Alocação de Recursos Para Medicamentos”. Ministério da Saúde de Moçambique 2011.
Zurück zum Zitat COWI. Finalização do plano de negócios da SMM: situação dos mercados farmacêuticos Em Moçambique E Na Região Da SADC. Maputo: COWI Consulting, Africa; 2012. COWI. Finalização do plano de negócios da SMM: situação dos mercados farmacêuticos Em Moçambique E Na Região Da SADC. Maputo: COWI Consulting, Africa; 2012.
Zurück zum Zitat De Oliveira L. Inicitativa de instalação Da fábrica de antiretrovirrais E outros medicamentos Em moçambique; avaliação Do projecto”. Fundação Oswaldo Cruz: Farmanguinhos; 2013. De Oliveira L. Inicitativa de instalação Da fábrica de antiretrovirrais E outros medicamentos Em moçambique; avaliação Do projecto”. Fundação Oswaldo Cruz: Farmanguinhos; 2013.
Zurück zum Zitat Froese EH. Meeting the pharmaceutical needs of a developing country. World Health Forum. 1991;12(1):25–8. Froese EH. Meeting the pharmaceutical needs of a developing country. World Health Forum. 1991;12(1):25–8.
Zurück zum Zitat GoM. Diploma ministerial No52/2010 Sobre Fixação de Preços de Medicamentos. 2010. GoM. Diploma ministerial No52/2010 Sobre Fixação de Preços de Medicamentos. 2010.
Zurück zum Zitat MISAU. “Plano Estratégico Da Área Farmacêutica”. Departamento Farmacêutico do Ministério da Saúde da República de Moçambique. 1996. MISAU. “Plano Estratégico Da Área Farmacêutica”. Departamento Farmacêutico do Ministério da Saúde da República de Moçambique. 1996.
Zurück zum Zitat Mujinja PGM, Mackintosh M, Justin-Temu M, Wuyts M. Local production of pharmaceuticals in Africa and access to essential medicines: ‘urban bias’ in access to imported medicines in Tanzania and its policy implications. Glob Health. 2014;10(1):12. doi:10.1186/1744-8603-10-12.CrossRef Mujinja PGM, Mackintosh M, Justin-Temu M, Wuyts M. Local production of pharmaceuticals in Africa and access to essential medicines: ‘urban bias’ in access to imported medicines in Tanzania and its policy implications. Glob Health. 2014;10(1):12. doi:10.​1186/​1744-8603-10-12.CrossRef
Zurück zum Zitat Osewe PL, Nkrumah YK, Sackey EK. Improving access to HIV/AIDS medicines in Africa: Trade-Related Aspects of Intellectual Property Rights (TRIPS) flexibilities utilization. World Bank Publications. 2008. Osewe PL, Nkrumah YK, Sackey EK. Improving access to HIV/AIDS medicines in Africa: Trade-Related Aspects of Intellectual Property Rights (TRIPS) flexibilities utilization. World Bank Publications. 2008.
Zurück zum Zitat Pavignani E, Durão JR. Managing external resources in Mozambique: building new aid relationships on shifting sands? Health Policy Plan. 1999;14(3):243–53.CrossRef Pavignani E, Durão JR. Managing external resources in Mozambique: building new aid relationships on shifting sands? Health Policy Plan. 1999;14(3):243–53.CrossRef
Zurück zum Zitat Pfeiffer J, Montoya P, Alberto J, Baptista MK, de Morais M, Pugas MM, et al. Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique—a case study. J Int AIDS Soc. 2010;13(1):3. doi:10.1186/1758-2652-13-3.CrossRef Pfeiffer J, Montoya P, Alberto J, Baptista MK, de Morais M, Pugas MM, et al. Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique—a case study. J Int AIDS Soc. 2010;13(1):3. doi:10.​1186/​1758-2652-13-3.CrossRef
Zurück zum Zitat Rovira J. Creating and promoting domestic drug manufacturing capacities: a solution for developing countries? In: In Negot heal intellect prop access mediciens. Sterling: International Centre for Trade and Sustainable Development; 2006. Rovira J. Creating and promoting domestic drug manufacturing capacities: a solution for developing countries? In: In Negot heal intellect prop access mediciens. Sterling: International Centre for Trade and Sustainable Development; 2006.
Zurück zum Zitat Russo G, McPake B. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings. Health Policy Plan. 2010;25(1):70–84. doi:10.1093/heapol/czp042.CrossRef Russo G, McPake B. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings. Health Policy Plan. 2010;25(1):70–84. doi:10.​1093/​heapol/​czp042.CrossRef
Zurück zum Zitat Russo G, Cabral L, Ferrinho P. Brazil-Africa technical cooperation in health: what’s its relevance to the post-Busan debate on ‘aid effectiveness’? Glob Health. 2013;9:2. doi:10.1186/1744-8603-9-2.CrossRef Russo G, Cabral L, Ferrinho P. Brazil-Africa technical cooperation in health: what’s its relevance to the post-Busan debate on ‘aid effectiveness’? Glob Health. 2013;9:2. doi:10.​1186/​1744-8603-9-2.CrossRef
Zurück zum Zitat Russo G, de Oliveira L, Shankland A, Sitoe T. On the margins of aid orthodoxy: the Brazil-Mozambique collaboration to produce essential medicines in Africa. Glob Health. 2014;10(1):70. doi:10.1186/s12992-014-0070-z.CrossRef Russo G, de Oliveira L, Shankland A, Sitoe T. On the margins of aid orthodoxy: the Brazil-Mozambique collaboration to produce essential medicines in Africa. Glob Health. 2014;10(1):70. doi:10.​1186/​s12992-014-0070-z.CrossRef
Zurück zum Zitat Shadlen KC, Fonseca E. Health policy as industrial policy: Brazil in comparative perspective. Polit Soc. 2013;41(4):561–87.CrossRef Shadlen KC, Fonseca E. Health policy as industrial policy: Brazil in comparative perspective. Polit Soc. 2013;41(4):561–87.CrossRef
Zurück zum Zitat SMM, and Farmanguinhos. Plano de negócios Da SMM. Matola: Sociedade Moçambicana de Medicamentos; 2013. SMM, and Farmanguinhos. Plano de negócios Da SMM. Matola: Sociedade Moçambicana de Medicamentos; 2013.
Zurück zum Zitat Turshen M. Reprivatizing pharmaceutical supplies in Africa. J Public Health Policy. 2001;22(2):198–225.CrossRef Turshen M. Reprivatizing pharmaceutical supplies in Africa. J Public Health Policy. 2001;22(2):198–225.CrossRef
Zurück zum Zitat UNIDO. Pharmaceutical sector profile: Uganda. Global UNIDO project: strengthening the local production of essential generic drugs in least developed and developing countries. Vienna: United Nations Industrial Development Organization; 2010. UNIDO. Pharmaceutical sector profile: Uganda. Global UNIDO project: strengthening the local production of essential generic drugs in least developed and developing countries. Vienna: United Nations Industrial Development Organization; 2010.
Zurück zum Zitat UNIDO. Pharmaceutical sector profile: Zimbabwe. Global UNIDO project: strengthening the local production of essential generic drugs in least developed and developing countries. Vienna: United Nations Industrial Development Organization; 2011. UNIDO. Pharmaceutical sector profile: Zimbabwe. Global UNIDO project: strengthening the local production of essential generic drugs in least developed and developing countries. Vienna: United Nations Industrial Development Organization; 2011.
Zurück zum Zitat UNIDO-AUC. Pharmaceutical manufacturing plan for Africa—business plan. Prepared as part of the African union commission-UNIDO partnership. Addis Ababa: United Nations Industrial development Organization; 2012. UNIDO-AUC. Pharmaceutical manufacturing plan for Africa—business plan. Prepared as part of the African union commission-UNIDO partnership. Addis Ababa: United Nations Industrial development Organization; 2012.
Zurück zum Zitat Waning B, Diedrichsen E, Moon S. A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. J Int AIDS Soc. 2010;13:35. doi:10.1186/1758-2652-13-35.CrossRef Waning B, Diedrichsen E, Moon S. A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. J Int AIDS Soc. 2010;13:35. doi:10.​1186/​1758-2652-13-35.CrossRef
Metadaten
Titel
Re-Thinking Pharmaceutical Production in Africa; Insights from the Analysis of the Local Manufacturing Dynamics in Mozambique and Zimbabwe
verfasst von
Giuliano Russo
Geoffrey Banda
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Studies in Comparative International Development / Ausgabe 2/2015
Print ISSN: 0039-3606
Elektronische ISSN: 1936-6167
DOI
https://doi.org/10.1007/s12116-015-9186-2

Weitere Artikel der Ausgabe 2/2015

Studies in Comparative International Development 2/2015 Zur Ausgabe